Cargando…

Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination

Tularemia is a highly infectious and contagious disease caused by the bacterium Francisella tularensis. To better understand human response to a live-attenuated tularemia vaccine and the biological pathways altered post-vaccination, healthy adults were vaccinated, and plasma was collected pre- and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Maner-Smith, Kristal M., Goll, Johannes B., Khadka, Manoj, Jensen, Travis L., Colucci, Jennifer K., Gelber, Casey E., Albert, Carolyn J., Bosinger, Steven E., Franke, Jacob D., Natrajan, Muktha, Rouphael, Nadine, Johnson, Robert A., Sanz, Patrick, Anderson, Evan J., Hoft, Daniel F., Mulligan, Mark J., Ford, David A., Ortlund, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564507/
https://www.ncbi.nlm.nih.gov/pubmed/32722213
http://dx.doi.org/10.3390/vaccines8030414
_version_ 1783595731154632704
author Maner-Smith, Kristal M.
Goll, Johannes B.
Khadka, Manoj
Jensen, Travis L.
Colucci, Jennifer K.
Gelber, Casey E.
Albert, Carolyn J.
Bosinger, Steven E.
Franke, Jacob D.
Natrajan, Muktha
Rouphael, Nadine
Johnson, Robert A.
Sanz, Patrick
Anderson, Evan J.
Hoft, Daniel F.
Mulligan, Mark J.
Ford, David A.
Ortlund, Eric A.
author_facet Maner-Smith, Kristal M.
Goll, Johannes B.
Khadka, Manoj
Jensen, Travis L.
Colucci, Jennifer K.
Gelber, Casey E.
Albert, Carolyn J.
Bosinger, Steven E.
Franke, Jacob D.
Natrajan, Muktha
Rouphael, Nadine
Johnson, Robert A.
Sanz, Patrick
Anderson, Evan J.
Hoft, Daniel F.
Mulligan, Mark J.
Ford, David A.
Ortlund, Eric A.
author_sort Maner-Smith, Kristal M.
collection PubMed
description Tularemia is a highly infectious and contagious disease caused by the bacterium Francisella tularensis. To better understand human response to a live-attenuated tularemia vaccine and the biological pathways altered post-vaccination, healthy adults were vaccinated, and plasma was collected pre- and post-vaccination for longitudinal lipidomics studies. Using tandem mass spectrometry, we fully characterized individual lipid species within predominant lipid classes to identify changes in the plasma lipidome during the vaccine response. Separately, we targeted oxylipins, a subset of lipid mediators involved in inflammatory pathways. We identified 14 differentially abundant lipid species from eight lipid classes. These included 5-hydroxyeicosatetraenoic acid (5-HETE) which is indicative of lipoxygenase activity and, subsequently, inflammation. Results suggest that 5-HETE was metabolized to a dihydroxyeicosatrienoic acid (DHET) by day 7 post-vaccination, shedding light on the kinetics of the 5-HETE-mediated inflammatory response. In addition to 5-HETE and DHET, we observed pronounced changes in 34:1 phosphatidylinositol, anandamide, oleamide, ceramides, 16:1 cholesteryl ester, and other glycerophospholipids; several of these changes in abundance were correlated with serum cytokines and T cell activation. These data provide new insights into alterations in plasma lipidome post-tularemia vaccination, potentially identifying key mediators and pathways involved in vaccine response and efficacy.
format Online
Article
Text
id pubmed-7564507
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75645072020-10-29 Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination Maner-Smith, Kristal M. Goll, Johannes B. Khadka, Manoj Jensen, Travis L. Colucci, Jennifer K. Gelber, Casey E. Albert, Carolyn J. Bosinger, Steven E. Franke, Jacob D. Natrajan, Muktha Rouphael, Nadine Johnson, Robert A. Sanz, Patrick Anderson, Evan J. Hoft, Daniel F. Mulligan, Mark J. Ford, David A. Ortlund, Eric A. Vaccines (Basel) Article Tularemia is a highly infectious and contagious disease caused by the bacterium Francisella tularensis. To better understand human response to a live-attenuated tularemia vaccine and the biological pathways altered post-vaccination, healthy adults were vaccinated, and plasma was collected pre- and post-vaccination for longitudinal lipidomics studies. Using tandem mass spectrometry, we fully characterized individual lipid species within predominant lipid classes to identify changes in the plasma lipidome during the vaccine response. Separately, we targeted oxylipins, a subset of lipid mediators involved in inflammatory pathways. We identified 14 differentially abundant lipid species from eight lipid classes. These included 5-hydroxyeicosatetraenoic acid (5-HETE) which is indicative of lipoxygenase activity and, subsequently, inflammation. Results suggest that 5-HETE was metabolized to a dihydroxyeicosatrienoic acid (DHET) by day 7 post-vaccination, shedding light on the kinetics of the 5-HETE-mediated inflammatory response. In addition to 5-HETE and DHET, we observed pronounced changes in 34:1 phosphatidylinositol, anandamide, oleamide, ceramides, 16:1 cholesteryl ester, and other glycerophospholipids; several of these changes in abundance were correlated with serum cytokines and T cell activation. These data provide new insights into alterations in plasma lipidome post-tularemia vaccination, potentially identifying key mediators and pathways involved in vaccine response and efficacy. MDPI 2020-07-24 /pmc/articles/PMC7564507/ /pubmed/32722213 http://dx.doi.org/10.3390/vaccines8030414 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maner-Smith, Kristal M.
Goll, Johannes B.
Khadka, Manoj
Jensen, Travis L.
Colucci, Jennifer K.
Gelber, Casey E.
Albert, Carolyn J.
Bosinger, Steven E.
Franke, Jacob D.
Natrajan, Muktha
Rouphael, Nadine
Johnson, Robert A.
Sanz, Patrick
Anderson, Evan J.
Hoft, Daniel F.
Mulligan, Mark J.
Ford, David A.
Ortlund, Eric A.
Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
title Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
title_full Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
title_fullStr Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
title_full_unstemmed Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
title_short Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination
title_sort alterations in the human plasma lipidome in response to tularemia vaccination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564507/
https://www.ncbi.nlm.nih.gov/pubmed/32722213
http://dx.doi.org/10.3390/vaccines8030414
work_keys_str_mv AT manersmithkristalm alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT golljohannesb alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT khadkamanoj alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT jensentravisl alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT coluccijenniferk alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT gelbercaseye alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT albertcarolynj alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT bosingerstevene alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT frankejacobd alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT natrajanmuktha alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT rouphaelnadine alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT johnsonroberta alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT sanzpatrick alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT andersonevanj alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT hoftdanielf alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT mulliganmarkj alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT forddavida alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination
AT ortlunderica alterationsinthehumanplasmalipidomeinresponsetotularemiavaccination